Formulation Development

Though excipients were at one time assumed to be “inactive” ingredients, it is now understood that excipients can have an important impact on the pharmaceutical and chemical performance of a drug product formulation. It’s therefore important to identify and control unknown FRCs of excipient materials, to manage their effects on pharmacodynamics and pharmacokinetics and achieve safe, robust and stable products.

Our extensive experience in formulation development and excipient characterization enables us to explain observed formulation characteristics or to appoint product specific FRCs.

Excipia can help your company to identify critical FRCs and (combinations of) excipients in a formulation, investigate batch-to-batch variability, select specific excipient batches or set in-house specifications for customized product properties.

Logo Avivia CMYK

Excipia, a division of Avivia BV

 Excipia as dedicated excipient knowledge platform is a division of Avivia BV, a Dutch independent specialized pharmaceutical development company that operates a hybrid business model combining CRO service activities with internal product development programs. The other complementary platforms of Avivia are Pharmaceutical R&D, Analytical R&D, and Biorelevant Dissolution Testing. For more information about Avivia and its pharmaceutical development CRO services, please visit the Avivia website.